Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...

Abbott is asking users of its FreeStyle Libre 3 diabetes monitors to check the serial numbers of their sensors after the company found that a limited number could provide incorrectly high glucose ...

FILE PHOTO: A logo of Abbott at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo (Reuters) -Abbott ...

A subset of FreeStyle Libre 3 and Libre 3 Plus sensors can give falsely low glucose readings Only specific Libre 3 and Libre 3 Plus sensors are affected. Abbott, the manufacturer of FreeStyle Libre, ...

Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...

Nearly two years after going live in Europe, the latest version of Abbott’s FreeStyle Libre continuous glucose monitor is ready to make its stateside debut. The FDA cleared the FreeStyle Libre 3 ...

Credit: Abbott. The FreeStyle Libre 3 reader is a standalone, small handheld device that displays real-time glucose readings. The Food and Drug Administration (FDA) has cleared a standalone reader to ...

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...